Jürgen Drews, M.D., Ph.D. (Chairman)
Consultant, Bear Stearns Health Innoventure Fund LLC, New York, NY, USA
Other Board memberships:
Human Genome Sciences, Inc., Rockville, MD, USA
MorphoSys AG, Martinsried/Munich, Germany (Vice Chairman)
Michael Lytton, J.D., M.Sc. (Vice Chairman)
General Partner, Oxford Bioscience Partners, Boston, MA, USA
Other Board memberships:
Acambis, plc., Cambridge, U.K. (until April 2006)
Alantos Pharmaceuticals, Inc., Cambridge, MA, USA
Claros Diagnostics Inc., Woburn, MA, USA (since December 2006)
Decision Biomarkers, Inc., Waltham, MA, USA
Enanta Pharmaceuticals, Inc., Watertown, MA, USA
Rib-X Pharmaceuticals, Inc., New Haven, CT, USA
Santhera Pharmaceuticals AG, Liestal, Switzerland (Chairman)
VaxInnate Pharmaceuticals, Inc., Cranbury, NJ, USA
Metin Colpan, Ph.D.
Founder and Member of the Supervisory Board of Qiagen N.V., Hilden, Germany
Other Board memberships:
MorphoSys AG, Martinsried/Munich, Germany
GenPat77 Pharmacogenetics AG, Berlin, Germany
James Frates
Chief Financial Officer, Alkermes, Inc., Cambridge, MA, USA
Peter Preuss
Regent, University of California
President, The Preuss Foundation, Inc., La Jolla, CA, USA
Donald Soltysiak
Consultant to the biopharmaceutical industry
NOTE: Board memberships include comparable domestic and foreign supervisory bodies of commercial enterprises.
Last Update: May 2008
